Literature DB >> 16251285

Photodynamic sensitization of Leishmania amazonensis in both extracellular and intracellular stages with aluminum phthalocyanine chloride for photolysis in vitro.

Sujoy Dutta1, Debalina Ray, Bala K Kolli, Kwang-Poo Chang.   

Abstract

Leishmania amazonensis, a causative agent of cutaneous leishmaniasis, is susceptible in vitro to light-mediated cytolysis in the presence of or after pretreatment with the photosensitizer aluminum phthalocyanine chloride. Cytolysis of both promastigotes and axenic amastigotes required less photosensitizer (e.g., one microg.ml(-1)) and a lower light dose (e.g., 1.5 J.cm(-2)) than did the mammalian cells examined for comparison. Exposure of Leishmania cells to the photosensitizer alone had little effect on their viability, as judged from their motility, growth, and/or retention of green fluorescent proteins genetically engineered for episomal expression. Fluorimetric assays for cell-associated and released green fluorescence proteins proved to be even more sensitive for the evaluation of cell viability than microscopy for the evaluation of motility and/or integrity. Axenic amastigotes pretreated with the photosensitizer infected macrophages of the J774 line but were lysed intracellularly when the infected cells were exposed to light. Addition of the photosensitizer to the already infected cells produced no effect on their intracellular parasites. However, light irradiation lysed these macrophages and also those infected with parasites preincubated with the photosensitizer at a concentration of 5 microg.ml(-1) or higher. Photosensitized Leishmania cells are highly susceptible to cytolysis, apparently due to the generation of reactive oxidative species on light illumination, suggestive of inefficiency of their antioxidant mechanisms. Efficient delivery of photosensitizers to intracellular Leishmania is expected to increase their therapeutic potentials against leishmaniasis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16251285      PMCID: PMC1280132          DOI: 10.1128/AAC.49.11.4474-4484.2005

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  30 in total

1.  Treatment of cutaneous leishmaniasis with photodynamic therapy.

Authors:  Claes D Enk; Clemens Fritsch; Flory Jonas; Abedelmajeed Nasereddin; Arieh Ingber; Charles L Jaffe; Thomas Ruzicka
Journal:  Arch Dermatol       Date:  2003-04

2.  Cloning and characterization of three differentially expressed peroxidoxin genes from Leishmania chagasi. Evidence for an enzymatic detoxification of hydroxyl radicals.

Authors:  S D Barr; L Gedamu
Journal:  J Biol Chem       Date:  2001-07-03       Impact factor: 5.157

3.  Photosensitizers neutral red (type I) and rose bengal (type II) cause light-dependent toxicity in Chlamydomonas reinhardtii and induce the Gpxh gene via increased singlet oxygen formation.

Authors:  Beat B Fischer; Anja Krieger-Liszkay; Rik L Eggen
Journal:  Environ Sci Technol       Date:  2004-12-01       Impact factor: 9.028

Review 4.  Porphyrins in photodynamic therapy - a search for ideal photosensitizers.

Authors:  S K Pushpan; S Venkatraman; V G Anand; J Sankar; D Parmeswaran; S Ganesan; T K Chandrashekar
Journal:  Curr Med Chem Anticancer Agents       Date:  2002-03

5.  Efficacy of thermotherapy to treat cutaneous leishmaniasis caused by Leishmania tropica in Kabul, Afghanistan: a randomized, controlled trial.

Authors:  R Reithinger; M Mohsen; M Wahid; M Bismullah; R J Quinnell; C R Davies; J Kolaczinski; J R David
Journal:  Clin Infect Dis       Date:  2005-03-16       Impact factor: 9.079

6.  Oxidized low-density lipoprotein as a delivery system for photosensitizers: implications for photodynamic therapy of atherosclerosis.

Authors:  H E de Vries; A C Moor; T M Dubbelman; T J van Berkel; J Kuiper
Journal:  J Pharmacol Exp Ther       Date:  1999-04       Impact factor: 4.030

7.  Genetic rescue of Leishmania deficiency in porphyrin biosynthesis creates mutants suitable for analysis of cellular events in uroporphyria and for photodynamic therapy.

Authors:  Jerome Franklin Sah; Hiroya Ito; Bala Krishna Kolli; Daniel A Peterson; Shigeru Sassa; Kwang-Poo Chang
Journal:  J Biol Chem       Date:  2002-02-08       Impact factor: 5.157

8.  Complementary antioxidant defense by cytoplasmic and mitochondrial peroxiredoxins in Leishmania infantum.

Authors:  Helena Castro; Carla Sousa; Marta Santos; Anabela Cordeiro-da-Silva; Leopold Flohé; Ana M Tomás
Journal:  Free Radic Biol Med       Date:  2002-12-01       Impact factor: 7.376

9.  A microplate assay for Leishmania amazonensis promastigotes expressing multimeric green fluorescent protein.

Authors:  Marion Man-Ying Chan; J Chloe Bulinski; Kwang-Poo Chang; Dunne Fong
Journal:  Parasitol Res       Date:  2002-10-23       Impact factor: 2.289

Review 10.  Leishmania model for microbial virulence: the relevance of parasite multiplication and pathoantigenicity.

Authors:  Kwang-Poo Chang; Steven G Reed; Bradford S McGwire; Lynn Soong
Journal:  Acta Trop       Date:  2003-03       Impact factor: 3.112

View more
  27 in total

1.  Delta-aminolevulinate-induced host-parasite porphyric disparity for selective photolysis of transgenic Leishmania in the phagolysosomes of mononuclear phagocytes: a potential novel platform for vaccine delivery.

Authors:  Sujoy Dutta; Celia Chang; Bala Krishna Kolli; Shigeru Sassa; Malik Yousef; Michael Showe; Louise Showe; Kwang-Poo Chang
Journal:  Eukaryot Cell       Date:  2012-02-03

2.  Photodynamic vaccination of hamsters with inducible suicidal mutants of Leishmania amazonensis elicits immunity against visceral leishmaniasis.

Authors:  Shraddha Kumari; Mukesh Samant; Prashant Khare; Pragya Misra; Sujoy Dutta; Bala Krishna Kolli; Sharad Sharma; Kwang Poo Chang; Anuradha Dube
Journal:  Eur J Immunol       Date:  2009-01       Impact factor: 5.532

Review 3.  Exploiting knowledge on pharmacodynamics-pharmacokinetics for accelerated anti-leishmanial drug discovery/development.

Authors:  Shyam Sundar; Neha Agrawal; Bhawana Singh
Journal:  Expert Opin Drug Metab Toxicol       Date:  2019-06-17       Impact factor: 4.481

4.  Combinational sensitization of Leishmania with uroporphyrin and aluminum phthalocyanine synergistically enhances their photodynamic inactivation in vitro and in vivo.

Authors:  Sujoy Dutta; Kayoko Waki; Kwang Poo Chang
Journal:  Photochem Photobiol       Date:  2012-01-25       Impact factor: 3.421

5.  Topical and Intradermal Efficacy of Photodynamic Therapy with Methylene Blue and Light-Emitting Diode in the Treatment of Cutaneous Leishmaniasis Caused by Leishmania braziliensis.

Authors:  Mônica Raquel Sbeghen; Evandra Maria Voltarelli; Tácito Graminha Campois; Elza Kimura; Sandra Mara Alessi Aristides; Luzmarina Hernandes; Wilker Caetano; Noboru Hioka; Maria Valdrinez Campana Lonardoni; Thaís Gomes Verzignassi Silveira
Journal:  J Lasers Med Sci       Date:  2015-06-28

6.  Pathogenic role of B cells and antibodies in murine Leishmania amazonensis infection.

Authors:  Nanchaya Wanasen; Lijun Xin; Lynn Soong
Journal:  Int J Parasitol       Date:  2007-09-20       Impact factor: 3.981

Review 7.  Modulation of dendritic cell function by Leishmania parasites.

Authors:  Lynn Soong
Journal:  J Immunol       Date:  2008-04-01       Impact factor: 5.422

8.  Down-regulation of dendritic cell signaling pathways by Leishmania amazonensis amastigotes.

Authors:  Lijun Xin; Kui Li; Lynn Soong
Journal:  Mol Immunol       Date:  2008-06-05       Impact factor: 4.407

9.  Role of natural killer cells in modulating dendritic cell responses to Leishmania amazonensis infection.

Authors:  Mayra X Hernandez Sanabria; Diego A Vargas-Inchaustegui; Lijun Xin; Lynn Soong
Journal:  Infect Immun       Date:  2008-09-15       Impact factor: 3.441

10.  Transgenic Leishmania model for delta-aminolevulinate-inducible monospecific uroporphyria: cytolytic phototoxicity initiated by singlet oxygen-mediated inactivation of proteins and its ablation by endosomal mobilization of cytosolic uroporphyrin.

Authors:  Sujoy Dutta; Bala Krishna Kolli; Aihua Tang; Shigeru Sassa; Kwang-Poo Chang
Journal:  Eukaryot Cell       Date:  2008-05-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.